FCGR3A and Hodgkins lymphoma: For instance, AFM13 has been combined with allogenic NK cells (ab-101) in treating R/R HL [214], and AFM24 (CD16 × EGFR) with autologous SNK01 NK cells, which do not require lymphodepletion [215].